These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3908611)

  • 41. Exogenous progesterone for luteal support following gonadotropin-releasing hormone ovulation induction: case report.
    Berger NG; Zacur HA
    Fertil Steril; 1985 Jul; 44(1):133-5. PubMed ID: 3891424
    [No Abstract]   [Full Text] [Related]  

  • 42. [Problem status and results of treatment with the "Zyklomat Pump"].
    Spitzer D; Haidbauer R; Staudach A; Batka M; Steiner H
    Gynakol Rundsch; 1990; 30 Suppl 1():244-6. PubMed ID: 2079287
    [No Abstract]   [Full Text] [Related]  

  • 43. Therapeutic strategies for ovulation induction in infertile women with polycystic ovary syndrome.
    Cristello F; Cela V; Artini PG; Genazzani AR
    Gynecol Endocrinol; 2005 Dec; 21(6):340-52. PubMed ID: 16390783
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [How to stimulate ovulation?].
    Fanard A; Picazo JJ
    Tokoginecol Pract; 1977 Oct; 36(409):807-32. PubMed ID: 339404
    [No Abstract]   [Full Text] [Related]  

  • 45. [Treatment of hypothalamic amenorrhea by pulsatile infusion of gonadotropin-releasing hormone].
    Bártfai G; Koloszár S; Sas M
    Orv Hetil; 1987 Jan; 128(2):73-6. PubMed ID: 3547241
    [No Abstract]   [Full Text] [Related]  

  • 46. New advances in ovulation induction.
    Kafy S; Tulandi T
    Curr Opin Obstet Gynecol; 2007 Jun; 19(3):248-52. PubMed ID: 17495641
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is luteinizing hormone needed for optimal ovulation induction?
    Balasch J; Fábregues F
    Curr Opin Obstet Gynecol; 2002 Jun; 14(3):265-74. PubMed ID: 12032381
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long term low dose pulsatile luteinizing hormone releasing hormone therapy for the treatment of anovulatory infertility.
    Tan SL; Thong PW; Chong R; Chua D; Tay BC; Jen SW; Aw SE; Salmon YM; Chen C
    Asia Oceania J Obstet Gynaecol; 1988 Sep; 14(3):327-33. PubMed ID: 3140773
    [No Abstract]   [Full Text] [Related]  

  • 49. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
    Elgindy EA; El-Haieg DO; El-Sebaey A
    Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Induction of ovulation].
    Andreoli C
    Minerva Ginecol; 1974 Mar; 26(3):147-58. PubMed ID: 4601305
    [No Abstract]   [Full Text] [Related]  

  • 51. [Recommendations of good practice: medicines that induce ovulation (June 2003)].
    AFSSAPS
    Gynecol Obstet Fertil; 2003; 31(7-8):676-86. PubMed ID: 14563614
    [No Abstract]   [Full Text] [Related]  

  • 52. Gonadotropin-releasing hormone (GnRH) antagonist plus recombinant luteinizing hormone vs. a standard GnRH agonist short protocol in patients at risk for poor ovarian response.
    De Placido G; Mollo A; Clarizia R; Strina I; Conforti S; Alviggi C
    Fertil Steril; 2006 Jan; 85(1):247-50. PubMed ID: 16412769
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of subcutaneous luteinising hormone releasing hormone in the induction of ovulation.
    Mason WP; Adams J; Tucker M; Jacobs HS
    Ups J Med Sci; 1984; 89(1):33-7. PubMed ID: 6377639
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Proceedings: Comparison between LH-RH test and various other ovulation induction methods in anovulation].
    Kurokawa H; To H; Maeda N; Asaoka K; Nakamura Y
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):363. PubMed ID: 4615931
    [No Abstract]   [Full Text] [Related]  

  • 55. [Use of GnRh analogues in the treatment of female sterility].
    Insler V; Lunenfeld B
    Contracept Fertil Sex; 1993; 21(7-8):538-42. PubMed ID: 8358444
    [No Abstract]   [Full Text] [Related]  

  • 56. Randomized comparison of different ovarian stimulation regimens for assisted reproductive technology in baboons (Papio anubis).
    Nyachieo A; Spiessens C; Chai DC; Debrock S; Mwenda JM; d'Hooghe TM
    Fertil Steril; 2011 Mar; 95(4):1354-9. PubMed ID: 20637458
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Experiments on the induction of ovulation in the mare, using a synthetic releasing-hormone analog].
    Humke R; Beaupoil J
    Berl Munch Tierarztl Wochenschr; 1979; 92(8):149-52. PubMed ID: 375932
    [No Abstract]   [Full Text] [Related]  

  • 58. Ovulation control in heifers with prostaglandin and luteinising hormone releasing hormone analogue under different conditions of management.
    Jackson PS; Furr BJ
    Res Vet Sci; 1983 Mar; 34(2):182-7. PubMed ID: 6222448
    [No Abstract]   [Full Text] [Related]  

  • 59. Aromatase inhibitors in ovulation induction.
    Mitwally MF; Casper RF
    Semin Reprod Med; 2004 Feb; 22(1):61-78. PubMed ID: 15083382
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The fate of conceptuses in rats receiving an intrauterine injection of luteinizing hormone-releasing hormone (LRH) prior to implantation.
    Jones RC
    Int J Fertil; 1981; 26(2):120-3. PubMed ID: 6114063
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.